| Patent No. | Patent Title: |
| 7993641 | Methods of treatment using anti-CD3 antibodies |
| 7994289 | Humanized anti-CD3 antibodies |
| 7985842 | Anti-IGF-I receptor antibody |
| 7981416 | Humanized immunomodulatory monoclonal antibodies for the treatmen... |
| 7977464 | Antibody molecules specific to human tumour necrosis factor alpha |
| 7968688 | Antibodies that bind to the C35 polypeptide |
| 7968093 | Fully human antibodies directed against the human insulin-like gr... |
| 7964711 | Compositions comprising polynucleotides encoding TACI-immunoglobu... |
| 7959935 | Simulated vernix compositions for skin cleansing and other applic... |
| 7951919 | TACI-immunoglobulin fusion proteins |
| 7943742 | Anti-αβantibodies and uses thereof |
| 7935794 | MAdCAM antibodies |
| 7919273 | Structural variants of antibodies for improved therapeutic charac... |
| 7919607 | Nucleic acids encoding humanized anti-tag 72 CC49 antbodies |
| 7915396 | Nucleic acid molecules encoding minimally immunogenic variants of... |
| 7893217 | Isolated human antibodies that bind epitopes on RG1 |
| 7887804 | Methods for treating disease-states associated with RG1 using imm... |
| 7888479 | Humanized antibodies against monocyte chemotactric proteins |
| 7884198 | Polynucleotides encoding humanized and chimeric antibodies specif... |
| 7879990 | Polynucleotides encoding antibodies that bind to the C35 polypept... |
| 7872102 | Anti-IL-23 antibodies |
| 7862814 | Method of inhibiting the proliferation of B cell cancers using TA... |
| 7850966 | Method of treating breast cancer using anti-HER2 antibody variant... |
| 7851601 | Monoclonal antibody capable of binding to heparin-binding epiderm... |
| 7834155 | CA6 antigen-specific cytotoxic conjugate and methods of using the... |
| 7833528 | Use of multispecific, non-covalent complexes for targeted deliver... |
| 7803915 | Antibody compositions for the diagnosis and treatment of tumor |
| 7799327 | Autoantibodies utilized as carrier agents for pharmaceutical comp... |
| 7795413 | Nucleic acids encoding human anti-NGF neutralizing antibodies as ... |
| 7790168 | Modulation of immunostimulatory activity of immunostimulatory oli... |
| 7776330 | Humanized anti-CEA T84.66 antibody and uses thereof |
| 7777017 | Nucleic acids encoding opsonic monoclonal and chimeric antibodies... |
| 7750124 | Anti-human DLL4 antibodies and compositions |
| 7749504 | Anti-TAT188 antibodies |
| 7732578 | Super humanized antibodies |
| 7723500 | Immunostimulatory nucleic acid molecules |
| 7718776 | Human anti-OPGL neutralizing antibodies as selective OPGL pathway... |
| 7696322 | Fusion antibodies |
| 7691380 | Combined methods for tumor coagulation and tumor treatment |
| 7683159 | Tenascin-W compositions and uses thereof |
Did You Know... 
PatentStorm News
